These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 19033885)

  • 1. Functional characterization of the RAD51D E233G genetic variant.
    Nadkarni A; Furda A; Rajesh C; McInnes C; Ruch RJ; Pittman DL
    Pharmacogenet Genomics; 2009 Feb; 19(2):153-60. PubMed ID: 19033885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin resistance conferred by the RAD51D (E233G) genetic variant is dependent upon p53 status in human breast carcinoma cell lines.
    Nadkarni A; Rajesh P; Ruch RJ; Pittman DL
    Mol Carcinog; 2009 Jul; 48(7):586-91. PubMed ID: 19347880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ATPase motif in RAD51D is required for resistance to DNA interstrand crosslinking agents and interaction with RAD51C.
    Gruver AM; Miller KA; Rajesh C; Smiraldo PG; Kaliyaperumal S; Balder R; Stiles KM; Albala JS; Pittman DL
    Mutagenesis; 2005 Nov; 20(6):433-40. PubMed ID: 16236763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive chromosomal instability in Rad51d-deficient mouse cells.
    Smiraldo PG; Gruver AM; Osborn JC; Pittman DL
    Cancer Res; 2005 Mar; 65(6):2089-96. PubMed ID: 15781618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction profile of homologous recombination repair proteins RAD51C, RAD51D and XRCC2 as determined by proteomic analysis.
    Rajesh C; Gruver AM; Basrur V; Pittman DL
    Proteomics; 2009 Aug; 9(16):4071-86. PubMed ID: 19658102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization and identification of mouse Rad51d splice variants.
    Gruver AM; Yard BD; McInnes C; Rajesh C; Pittman DL
    BMC Mol Biol; 2009 Mar; 10():27. PubMed ID: 19327148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional characterization of the N-terminal domain of human Rad51D.
    Kim YM; Choi BS
    Int J Biochem Cell Biol; 2011 Mar; 43(3):416-22. PubMed ID: 21111057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The variant E233G of the RAD51D gene could be a low-penetrance allele in high-risk breast cancer families without BRCA1/2 mutations.
    Rodríguez-López R; Osorio A; Ribas G; Pollán M; Sánchez-Pulido L; de la Hoya M; Ruibal A; Zamora P; Arias JI; Salazar R; Vega A; Martínez JI; Esteban-Cardeñosa E; Alonso C; Letón R; Urioste Azcorra M; Miner C; Armengod ME; Carracedo A; González-Sarmiento R; Caldés T; Díez O; Benítez J
    Int J Cancer; 2004 Jul; 110(6):845-9. PubMed ID: 15170666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparate requirements for the Walker A and B ATPase motifs of human RAD51D in homologous recombination.
    Wiese C; Hinz JM; Tebbs RS; Nham PB; Urbin SS; Collins DW; Thompson LH; Schild D
    Nucleic Acids Res; 2006; 34(9):2833-43. PubMed ID: 16717288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domain mapping of the Rad51 paralog protein complexes.
    Miller KA; Sawicka D; Barsky D; Albala JS
    Nucleic Acids Res; 2004; 32(1):169-78. PubMed ID: 14704354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RAD51D E233G variant and breast cancer risk: population-based and clinic-based family studies of Australian women.
    Dowty JG; Lose F; Jenkins MA; Chang JH; Chen X; Beesley J; Dite GS; Southey MC; Byrnes GB; Tesoriero A; Giles GG; Hopper JL; Spurdle AB; ;
    Breast Cancer Res Treat; 2008 Nov; 112(1):35-9. PubMed ID: 18058226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNF138 interacts with RAD51D and is required for DNA interstrand crosslink repair and maintaining chromosome integrity.
    Yard BD; Reilly NM; Bedenbaugh MK; Pittman DL
    DNA Repair (Amst); 2016 Jun; 42():82-93. PubMed ID: 27161866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAD51D splice variants and cancer-associated mutations reveal XRCC2 interaction to be critical for homologous recombination.
    Baldock RA; Pressimone CA; Baird JM; Khodakov A; Luong TT; Grundy MK; Smith CM; Karpenshif Y; Bratton-Palmer DS; Prakash R; Jasin M; Garcin EB; Gon S; Modesti M; Bernstein KA
    DNA Repair (Amst); 2019 Apr; 76():99-107. PubMed ID: 30836272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere maintenance requires the RAD51D recombination/repair protein.
    Tarsounas M; Muñoz P; Claas A; Smiraldo PG; Pittman DL; Blasco MA; West SC
    Cell; 2004 Apr; 117(3):337-47. PubMed ID: 15109494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A naturally occurring genetic variant of human XRCC2 (R188H) confers increased resistance to cisplatin-induced DNA damage.
    Danoy P; Sonoda E; Lathrop M; Takeda S; Matsuda F
    Biochem Biophys Res Commun; 2007 Jan; 352(3):763-8. PubMed ID: 17141189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a Cryptosporidium parvum protein that binds single-stranded G-strand telomeric DNA.
    Liu C; Wang L; Lancto CA; Abrahamsen MS
    Mol Biochem Parasitol; 2009 Jun; 165(2):132-41. PubMed ID: 19428660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homologous pairing and ring and filament structure formation activities of the human Xrcc2*Rad51D complex.
    Kurumizaka H; Ikawa S; Nakada M; Enomoto R; Kagawa W; Kinebuchi T; Yamazoe M; Yokoyama S; Shibata T
    J Biol Chem; 2002 Apr; 277(16):14315-20. PubMed ID: 11834724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orchestration of Haemophilus influenzae RecJ exonuclease by interaction with single-stranded DNA-binding protein.
    Sharma R; Rao DN
    J Mol Biol; 2009 Feb; 385(5):1375-96. PubMed ID: 19094995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding regions of outer membrane protein A in complexes with the periplasmic chaperone Skp. A site-directed fluorescence study.
    Qu J; Behrens-Kneip S; Holst O; Kleinschmidt JH
    Biochemistry; 2009 Jun; 48(22):4926-36. PubMed ID: 19382746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionally Null
    Rivera B; Di Iorio M; Frankum J; Nadaf J; Fahiminiya S; Arcand SL; Burk DL; Grapton D; Tomiak E; Hastings V; Hamel N; Wagener R; Aleynikova O; Giroux S; Hamdan FF; Dionne-Laporte A; Zogopoulos G; Rousseau F; Berghuis AM; Provencher D; Rouleau GA; Michaud JL; Mes-Masson AM; Majewski J; Bens S; Siebert R; Narod SA; Akbari MR; Lord CJ; Tonin PN; Orthwein A; Foulkes WD
    Cancer Res; 2017 Aug; 77(16):4517-4529. PubMed ID: 28646019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.